PepTune: De Novo Generation of Therapeutic Peptides with Multi-Objective-Guided Discrete Diffusion
Sophia Tang, Yinuo Zhang, Pranam Chatterjee
2024-12-26
Summary
This paper talks about PepTune, a new method for creating therapeutic peptides using a model that balances multiple important properties for better drug design.
What's the problem?
Designing therapeutic peptides, which are small proteins used in medicines, is difficult because they need to meet several conflicting requirements, like how well they bind to targets, how soluble they are in water, and how easily they can cross cell membranes. Traditional methods for drug development often struggle to optimize these properties at the same time, making it hard to create effective new treatments.
What's the solution?
To solve this problem, the authors developed PepTune, a multi-objective discrete diffusion model that generates and optimizes peptides. This model separates the design process into two parts: one focuses on the overall structure and movement of the peptide, while the other captures finer details and rapid changes. They use a technique called Monte Carlo Tree Search (MCTS) to explore different peptide designs efficiently and find the best combinations of properties. This allows them to create peptides that are optimized for various therapeutic uses.
Why it matters?
This research is important because it represents a significant advancement in drug design. By using AI to generate peptides that meet multiple objectives simultaneously, PepTune can help speed up the discovery of new medicines for diseases like cancer and diabetes. This approach could lead to more effective treatments with fewer side effects, ultimately improving patient care.
Abstract
Peptide therapeutics, a major class of medicines, have achieved remarkable success across diseases such as diabetes and cancer, with landmark examples such as GLP-1 receptor agonists revolutionizing the treatment of type-2 diabetes and obesity. Despite their success, designing peptides that satisfy multiple conflicting objectives, such as target binding affinity, solubility, and membrane permeability, remains a major challenge. Classical drug development and structure-based design are ineffective for such tasks, as they fail to optimize global functional properties critical for therapeutic efficacy. Existing generative frameworks are largely limited to continuous spaces, unconditioned outputs, or single-objective guidance, making them unsuitable for discrete sequence optimization across multiple properties. To address this, we present PepTune, a multi-objective discrete diffusion model for the simultaneous generation and optimization of therapeutic peptide SMILES. Built on the Masked Discrete Language Model (MDLM) framework, PepTune ensures valid peptide structures with state-dependent masking schedules and penalty-based objectives. To guide the diffusion process, we propose a Monte Carlo Tree Search (MCTS)-based strategy that balances exploration and exploitation to iteratively refine Pareto-optimal sequences. MCTS integrates classifier-based rewards with search-tree expansion, overcoming gradient estimation challenges and data sparsity inherent to discrete spaces. Using PepTune, we generate diverse, chemically-modified peptides optimized for multiple therapeutic properties, including target binding affinity, membrane permeability, solubility, hemolysis, and non-fouling characteristics on various disease-relevant targets. In total, our results demonstrate that MCTS-guided discrete diffusion is a powerful and modular approach for multi-objective sequence design in discrete state spaces.